Condition
Motor Neuron Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 18 Motor Neuron Disease clinical trials that are recruiting, at sites in 16 countries (most in United States (9), United Kingdom (3), Italy (3)). 1 was first registered in the last 30 days. By phase: Phase 1 (1). The most active sponsors are National Institutes of Health Clinical Center (CC) (4), Istituto Auxologico Italiano (2), Neuralink Corp (2). There are also 14 NIH-funded research projects on Motor Neuron Disease, with $10.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 18Clinical trials
- 14NIH research projects
- 1New in 30 days
- 16Countries
Newest Motor Neuron Disease clinical trials
All recruiting trials (18)
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
How physical functioning relates to quality of life for people with ALS at TidalHealth
This study will see if physical functioning scores relate to quality of life for adults with ALS who receive care at TidalHealth Peninsula Regional.
-
Acamprosate for ALS with C9orf72 mutation
This study tests whether acamprosate can be safely used to see if it helps people with ALS who carry a C9orf72 mutation.
-
Robotically implanted Neuralink N1 brain-computer interface to control external devices
This study will test whether a robotically implanted Neuralink N1 brain-computer interface can safely help people with high spinal cord injuries or ALS control computers and other external devices.
-
Robotically implanted brain chip to help control external devices
This tests a wireless, rechargeable brain implant (Neuralink N1) and a robot surgical system (R1) to help people with severe arm and hand paralysis control external devices.
-
Observational study on amyotrophic lateral sclerosis
This study is collecting health information from people with ALS, those with related genetic mutations, and healthy volunteers to help improve treatments and understand the disease better.
-
Digital app for monitoring speech and health in neurodegenerative conditions
This study is testing a digital app that records and analyzes speech to see if it can help monitor and detect neurodegenerative conditions like dementia and Parkinson's disease in both patients and healthy volunteers.
-
Understanding the variability in ALS through biomarkers
This study is trying to see how different biological markers can help us understand the varying symptoms of ALS in patients and group them based on their unique characteristics.
-
Creating a database to study variations in motor neuron diseases
This study is trying to learn more about the different types of motor neuron diseases in patients to better understand the condition and improve how we predict its course.
-
Impact of long-term ventilation support on ALS patients and their families
This study is testing how long-term breathing support affects the quality of life for people with ALS and their families.
-
Genetic analysis of hereditary spastic paraplegia
This study is trying to find out the genetic causes of hereditary spastic paraplegia to help improve diagnosis and treatment for people living with this condition.
-
Using brain-computer interfaces to control assistive devices for motor recovery
This study tests whether using brain-computer interfaces can help people with motor disorders control assistive devices better and improve their movement skills.
-
Creating a biorepository of biofluids and clinical data for ALS research
This study is collecting blood, spinal fluid, and urine samples from people with ALS and healthy individuals to help find new ways to understand and treat the disease.
-
Understanding Spinal and Bulbar Muscular Atrophy through Biomarkers
This study is trying to understand how Spinal and Bulbar Muscular Atrophy affects people by collecting health information and tests from men over 18, both with and without the condition.
-
Assessing swallowing function in patients with neurodegenerative diseases
This study looks at how well people with neurodegenerative diseases, like Parkinson's and Motor Neuron Disease, can swallow and how it affects their quality of life.
-
Detecting awareness in patients with disorders of consciousness
This study tests if a special brain-monitoring technology can help doctors see if patients with severe consciousness disorders are aware and then teach those who are aware how to communicate.
-
Evaluating a new device for assessing muscle and nerve disorders
This study is testing a new device that uses electrical signals to see if it can help diagnose muscle and nerve disorders in both healthy people and those with neuromuscular diseases.
-
Understanding inherited neurological disorders
This study is trying to learn more about inherited neurological disorders by looking at the medical history and genetics of people who have or might have these conditions.
NIH-funded research (14)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
T cell roles in a rare juvenile ALS form (SETX-related)
A study to understand how immune cells, especially CD8 T cells, influence a rare juvenile form of ALS caused by SETX mutations.
-
Investigating how motor neurons contribute to premature death in spinocerebellar ataxia type 1
A study at Baylor College of Medicine is exploring why people with spinocerebellar ataxia type 1 also develop muscle weakness and breathing problems, and how motor neurons are involved.
-
Understanding how sphingolipid changes cause immune-nerve damage in ALS
A Johns Hopkins team tests how abnormal lipid production may drive motor neuron disease in people with ALS, using patient-derived cells and mouse models.
-
Blocking EphA4 to protect motor neurons in ALS
This project develops and refines drug-like molecules that target the EphA4 protein to try to protect motor neurons in people with ALS.
-
Early causes of frontotemporal dementia and motor neuron disease
Researchers are using donated brain tissue from people with genetic and non-genetic frontotemporal dementia and motor neuron disease to find early changes that lead to TDP-43 protein problems.
-
Motor neuron causes of weakness and breathing problems in spinocerebellar ataxia type 1
Seeing if damage to motor neurons explains muscle weakness, trouble breathing and early death in people with spinocerebellar ataxia type 1.
-
T cells in a rare juvenile form of ALS (ALS4)
This research looks at whether certain CD8 T immune cells are linked to ALS4, a rare juvenile form of ALS, by studying mouse models and samples from people with ALS.
-
Investigating a protein's role in neuron health and its link to motor neuron diseases.
This study is looking at a protein called Sec20 in fruit flies to see how its loss affects nerve cells and could be linked to motor neuron diseases like ALS and FTD, with the hope of finding new ways to help people with these conditions.
-
Targeting a specific protein to help treat motor neuron disease
This study is looking at a specific part of the body called the EphA4 receptor to find new treatments for ALS, a serious disease that affects movement, with the hope that these new therapies can help slow down or stop the disease for patients.
-
Investigating neuron dysfunction in ALS and its impact on motor control
This study is looking at how the loss of certain brain cells affects movement in people with ALS, using mice to learn more about the connections between these cells and the ones that control movement, with hopes of finding new ways to help treat the disease.
-
Understanding how a specific type of ALS spreads
This research explores how a specific type of ALS, called SOD1-ALS, might spread through the body like a prion, affecting how quickly the disease progresses.
-
Understanding how motor neuron disease affects patients with Spinocerebellar Ataxia Type 1
This study is looking at how nerve cells that control movement are affected in people with Spinocerebellar Ataxia Type 1 (SCA1) to better understand the disease and find new ways to help improve symptoms like muscle weakness and coordination problems.
-
How the Sec20 protein affects nerve cells and may relate to ALS and frontotemporal dementia
This project looks at whether changes in the Sec20 protein cause nerve cell damage through mitochondrial and recycling (autophagy) problems that link to adult-onset ALS and frontotemporal dementia.
-
Investigating brain changes in frontotemporal dementia and motor neuron disease.
This study is looking at how certain biological factors affect brain health in people with frontotemporal dementia and motor neuron disease, by examining brain tissue samples to better understand what makes these conditions unique and how they progress, and it includes both patients and healthy individuals to get a com
Related topics
Quick answers
How many Motor Neuron Disease clinical trials are recruiting right now?
18, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United States (9 trials), United Kingdom (3 trials), Italy (3 trials), Germany (2 trials), Norway (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.